ArticlemedRxiv : the preprint server for health sciences2025
A Scalable Framework to Integrate Social Determinants of Health into Disease Risk Models using Biobank Survey Data.
Article in medRxiv : the preprint server for health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Updated by
Authors and funding
7 authors.
Funding
Abstract
Complex diseases are a major global health burden, yet our ability to predict who is at risk remains limited. Risk is shaped by both heritable factors and non-genetic environmental, behavioral, and social determinants of health, but these are rarely modeled together. The growing availability of large-scale, multimodal biobanks creates new opportunities to integrate diverse data types into more accurate disease risk models. Here, we apply Multiple Correspondence Analysis (MCA) to over 100 environmental, behavioral, and social variables from the All of Us biobank (N = 171,614) to generate low-dimensional embeddings that quantify non-genetic risk for six common chronic conditions. These embeddings recovered known and novel risk factors and consistently improved prediction beyond demographics and polygenic scores (PGS), with contributions to model performance (ROC-AUC) ranging from 0.03 to 0.05. For five of six diseases, the gains from MCA embeddings surpassed those attributable to PGS. Genetic and non-genetic risks combined largely additively: we observed little evidence of interaction effects (ΔAUC < 0.001) and highly stable variant effect sizes when embeddings were included in genetic association models (
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.